PharmaCyte Biotech, Inc. business relationships
Companies named in PharmaCyte Biotech, Inc.’s 10-K filed 2026-07-29, and public companies whose annual reports name PharmaCyte Biotech, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 11% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in PharmaCyte Biotech, Inc.’s annual report 2
“| Collaboration Agreement, dated November 14, 2023, by and between PharmaCyte Biotech, Inc. and Femasys, Inc. |” SEC filing
“(the "Femasys Purchase Agreement") with Femasys Inc. ("Femasys"), pursuant to which we purchased from Femasys” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.